Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

This study has been completed.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Fox Chase Cancer Center

ClinicalTrials.gov Identifier:

NCT01637194

First received: October 20, 2011

Last updated: July 6, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2011
Primary Completion Date:	July 2011 (Final data collection date for primary outcome measure)